Crispr Therapeutics Ag (CRSP)

SBC to Revenue

170.08%

Quarterly · Period ending:

CRSP logo

CRSP SBC to Revenue

Latest reported170.08%
CRSP Quarterly SBC/Revenue (0.00% → 170.08%)
High-resolution chart · PNG

CRSP sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag SBC to Revenue — Quarterly
Period endingSBC to Revenue
170.0815%
1,119.6159%
2,092.1296%
1,867.7165%
1,973.8789%
2,336.6474%
62.7057%
3,578.5714%
4,578.7234%
3,850.1984%
9.21%
0%
31.0929%
20.875%
380,083.3333%
26,111.7021%
15,729.1139%
14,463.4831%
199.7674%
7,963.2219%
3.1472%
10,936.6337%
5,116.2162%
11,648.6486%
35,675%
9,013.3758%
15.3955%
5.3523%
3,517.6101%
2,948.4756%
11,326.087%
1,430.5506%
765.0735%
411.0457%
21.5901%
203.938%
91.569%
138.5868%
171.843%
148.031%
440.3774%
214.7059%
476.1134%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.